![](https://cdn.sanity.io/images/0vv8moc6/ajmc/6fde2ef02d397b2e25fc7a81b393532ef5585357-8658x5775.jpg?fit=crop&auto=format)
Apremilast Now Available in US for Pediatric Plaque Psoriasis
Amgen has announced the availability of apremilast (Otezla) in the United States for pediatric use, following approval by the FDA earlier this year.1 This marks the first oral treatment option for children and adolescents aged 6 years and older with …